Skip to main content
SpringerLink
Log in

Transitional Cell Cancer

  • Chapter
  • First Online:
Ureteroscopy

Part of the book series: Current Clinical Urology ((CCU))

  • 1498 Accesses

Abstract

Transitional cell carcinoma of the upper urinary tract (UUT-TCC) accounts for 5–10 % of all urothelial cancers. The diagnosis of UUT-TCC involves the use of radiological imaging, urinary cytology, and ureteroscopy with biopsies. The management of patients with UUT-TCC is dependent on patient co-morbidity and tumor factors. For localized disease, the gold standard is a radical nephroureterectomy but conservative management with ureteroscopic tumor ablation is indicated in selected patient groups. Conservative management requires close follow-up due to the high risk of tumor recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol. 2000;164(5):1523–5.

    Article  PubMed  CAS  Google Scholar 

  2. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology. 1998;52(4):594–601.

    Article  PubMed  CAS  Google Scholar 

  3. Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG. Upper Tract Urothelial Carcinoma Collaboration. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115(6):1224–33.

    Article  PubMed  Google Scholar 

  4. Olgac S, Mazumdar M, Dalbagni G, Reuter VE. Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. Am J Surg Pathol. 2004;28(12):1545–52.

    Article  PubMed  Google Scholar 

  5. Rouprêt M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R, Babjuk M, Oosterlinck W. Members of the European Association of Urology (EAU)Guidelines office. Guidelines on upper urinary tract urothelial cell carcinomas. In: EAU Guidelines edition presented at the 25th EAU Anaual Congress, Barcelona 2010. ISBN 978-90-79754-70-0.

    Google Scholar 

  6. Azémar MD, Comperat E, Richard F, Cussenot O, Rouprêt M. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol. 2011;29(2):130–6.

    Article  PubMed  Google Scholar 

  7. Colin P, Koenig P, Ouzzane A, Berthon N, Villers A, Biserte J, Rouprêt M. Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int. 2009;104(10):1436–40.

    Article  PubMed  CAS  Google Scholar 

  8. Pommer W, Bronder E, Klimpel A, Helmert U, Greiser E, Molzahn M. Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study. Nephrol Dial Transplant. 1999;14(12):2892–7.

    Article  PubMed  CAS  Google Scholar 

  9. Shinka T, Miyai M, Sawada Y, Inagaki T, Okawa T. Factors affecting the occurrence of urothelial tumors in dye workers exposed to aromatic amines. Int J Urol. 1995;2(4):243–8.

    Article  PubMed  CAS  Google Scholar 

  10. Painter DJ, Timoney AG, Denton K, Alken P, Keeley Jr FX. The modern management of upper tract urothelial cancer: tumour diagnosis, grading and staging. BJU Int. 2007;99:973–7.

    Article  PubMed  Google Scholar 

  11. Acher P, Kiela G, Thomas K, O’Brien T. Towards a rational strategy for the surveillance of patients with Lynch syndrome (hereditary non-polyposis colon cancer) for upper tract transitional cell carcinoma. BJU Int. 2010;106(3):300–2.

    Article  PubMed  Google Scholar 

  12. Rouprêt M, Yates DR, Comperat E, Cussenot O. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Eur Urol. 2008;54(6):1226–36.

    Article  PubMed  Google Scholar 

  13. Keeley FX, Bibbo M, McCue PA, Bagley DH. The use of p53 in the diagnosis of upper tract transitional cell carcinoma. Urology. 1997;49(2):181–6.

    Article  PubMed  Google Scholar 

  14. Oosterlinck W, Solsona E, van der Meijden AP, Sylvester R, Böhle A, Rintala E, Lobel B, European Association of Urology. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol. 2004;46(2):147–54.

    Article  PubMed  CAS  Google Scholar 

  15. Dillman JR, Caoili EM, Cohan RH, Ellis JH, Francis IR, Schipper MJ. Detection of upper tract urothelial neoplasms: sensitivity of axial, coronal reformatted, and curved-planar reformatted image-types utilizing 16-row multi-detector CT urography. Abdom Imaging. 2008;33(6):707–16.

    Article  PubMed  Google Scholar 

  16. Van Der Molen AJ, Cowan NC, Mueller-Lisse UG, Nolte-Ernsting CC, Takahashi S, Cohan RH. CT Urography Working Group of the European Society of Urogenital Radiology (ESUR). CT urography: definition, indications and techniques. A guideline for clinical practice. Eur Radiol. 2008;18(1):4–17.

    Article  Google Scholar 

  17. Wang LJ, Wong YC, Chuang CK, Huang CC, Pang ST. Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria. J Urol. 2009;181(2):524–31.

    Article  PubMed  Google Scholar 

  18. Wang LJ, Wong YC, Huang CC, Wu CH, Hung SC, Chen HW. Multidetector computerized tomography urography is more accurate than excretory urography for diagnosing transitional cell carcinoma of the upper urinary tract in adults with hematuria. J Urol. 2010;183(1):48–55.

    Article  PubMed  Google Scholar 

  19. Lang EK, Macchia RJ, Thomas R, Watson RA, Marberger M, Lechner G, Gayle B, Richter F. Improved detection of renal pathologic features on multiphasic helical CT compared with IVU in patients presenting with microscopic hematuria. Urology. 2003;61(3):528–32.

    Article  PubMed  Google Scholar 

  20. Buckley JA, Urban BA, Soyer P, Scherrer A, Fishmann EK. Transitional cell carcinoma of the renal pelvis: a retrospective look at CT staging with pathological correlation. Radiology. 1996;201:194–8.

    PubMed  CAS  Google Scholar 

  21. Takahashi N, Glockner JF, Hartman RP, King BF, Leibovich BC, Stanley DW, Fitz-Gibbon PD, Kawashima A. Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy. J Urol. 2010;183(4):1330–65.

    Article  PubMed  Google Scholar 

  22. Takahashi N, Kawashima A, Glockner JF, Hartman RP, Leibovich BC, Brau AC, Beatty PJ, King BF. Small (<2 cm) upper tract urothelial carcinoma: evaluation with gadolinium-enhanced three-dimensional spoiled gradient-recalled echo MR urography. Radiology. 2008;247(2):451–7.

    Article  PubMed  Google Scholar 

  23. Keeley FX, Bibbo M, Bagley DH. Ureteroscopic treatment and surveillance of upper tract transitional cell carcinoma. J Urol. 1997;157(5):1560–5.

    Article  PubMed  Google Scholar 

  24. Tavora F, Fajardo DA, Lee TK, Lotan T, Miller JS, Miyamoto H, Epstein JI. Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls. Am J Surg Pathol. 2009;33(10):1540–6.

    Article  PubMed  Google Scholar 

  25. Flanigan RC. Urothelial tumors of the upper urinary tract. In: Wein AJ, editor. Campbell-Walsh urology. 9th ed. Philadelphia: Saunders Elsevier; 2007. p. 1638–52.

    Google Scholar 

  26. Williams SK, Denton KJ, Minervini A, Oxley J, Khastigir J, Timoney AG, Keeley Jr FX. Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell carcinoma. J Endourol. 2008;22(1):71–6.

    Article  PubMed  Google Scholar 

  27. Perez-Montiel D, Wakely PE, Hes O, Michal M, Suster S. High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants. Mod Pathol. 2006;19(4):494–503.

    Article  PubMed  Google Scholar 

  28. Stewart GD, Bariol SV, Grigor KM, Tolley DA, McNeill SA. A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract. BJU Int. 2005;95(6):791–3.

    Article  PubMed  Google Scholar 

  29. Keeley FX, Kulp DA, Bibbo M, McCue PA, Bagley DH. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol. 1997;157:33–7.

    Article  PubMed  CAS  Google Scholar 

  30. Guarnizo E, Pavlovich CP, Seiba M, Carlson DL, Vaughan Jr ED, Sosa RE. Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. J Urol. 2000;163:52–5.

    Article  PubMed  CAS  Google Scholar 

  31. Papatsoris AG, Chrisofos M, Skolarikos A, Varkarakis I, Lekas A, Dellis A, Koritsiadis S, Deliveliotis C. Upper urinary tract transitional cell carcinoma. A 10-year experience. Tumori. 2008;94(1):75–8.

    PubMed  Google Scholar 

  32. Arancibia MF, Bolenz C, Michel M-S, Keeley Jr FX, Alken P. The modern management of upper urinary tract urothelial cancer: surgical treatment. BJU Int. 2007;99:978–81.

    Article  PubMed  Google Scholar 

  33. Abouassaly R, Alibhai SM, Shah N, Timilshina N, Fleshner N, Finelli A. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology. 2010;76(4):895–901.

    Article  PubMed  Google Scholar 

  34. Jeldres C, Sun M, Isbarn H, Lughezzani G, Budäus L, Alasker A, Shariat SF, Lattouf JB, Widmer H, Pharand D, Arjane P, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI. A population-based assessment of perioperative mortality after nephroureterectomy for upper tract urothelial carcinoma. Urology. 2010;75(2):315–20.

    Article  PubMed  Google Scholar 

  35. Kikuchi E, Margulis V, Karakiewicz PI, Roscigno M, Mikami S, Lotan Y, Remzi M, Bolenz C, Langner C, Weizer A, Montorsi F, Bensalah K, Koppie TM, Fernández MI, Raman JD, Kassouf W, Wood CG, Suardi N, Oya M, Shariat SF. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol. 2009;27(4):612–8.

    Article  PubMed  Google Scholar 

  36. Kim DS, Lee YH, Cho KS, Cho NH, Chung BH, Hong SJ. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma. Urology. 2010;75(2):328–32.

    Article  PubMed  Google Scholar 

  37. Novara G, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Bastian PJ, Martínez-Salamanca JI, Seitz C, Lemberger RJ, Burger M, El-Hakim A, Baba S, Martignoni G, Gupta A, Karakiewicz PI, Ficarra V, Shariat SF. Prognostic role of lymphovascular ­invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol. 2010;57(6):1064–71.

    Article  PubMed  Google Scholar 

  38. Zigeuner R, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Weizer A, Kikuchi E, Remzi M, Raman JD, Bolenz C, Bensalah K, Capitanio U, Koppie TM, Kassouf W, Sircar K, Patard JJ, Fernández MI, Wood CG, Montorsi F, Ströbel P, Wheat JC, Haitel A, Oya M, Guo CC, Ng C, Chade DC, Sagalowsky A, Langner C. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol. 2010;57(4):575–81.

    Article  PubMed  Google Scholar 

  39. Seitz C, Gupta A, Shariat SF, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Otto W, Tritschler S, Bastian PJ, Carballido J, Ficarra V, Karakiewicz PI, Artibani W, Mazzoleni G, Novara G. Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study. J Urol. 2010; 184(5):1895–900.

    Article  PubMed  Google Scholar 

  40. Wheat JC, Weizer AZ, Wolf Jr JS, Lotan Y, Remzi M, Margulis V, Wood CG, Montorsi F, Roscigno M, Kikuchi E, Zigeuner R, Langner C, Bolenz C, Koppie TM, Raman JD, Fernández M, Karakiewizc P, Capitanio U, Bensalah K, Patard JJ, Shariat SF. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol. 2010;30(3):252–8.

    PubMed  Google Scholar 

  41. Raman JD, Ng CK, Scherr DS, Margulis V, Lotan Y, Bensalah K, Patard JJ, Kikuchi E, Montorsi F, Zigeuner R, Weizer A, Bolenz C, Koppie TM, Isbarn H, Jeldres C, Kabbani W, Remzi M, Waldert M, Wood CG, Roscigno M, Oya M, Langner C, Wolf JS, Ströbel P, Fernández M, Karakiewcz P, Shariat SF. Impact of tumour location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol. 2010;57(6):1072–9.

    Article  PubMed  Google Scholar 

  42. Favaretto RL, Shariat SF, Chade DC, Godoy G, Adamy A, Kaag M, Bochner BH, Coleman J, Dalbagni G. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol. 2010;58(4):574–80.

    Article  PubMed  Google Scholar 

  43. Isbarn H, Jeldres C, Shariat SF, Liberman D, Sun M, Lughezzani G, Widmer H, Arjane P, Pharand D, Fisch M, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. J Urol. 2009;182(5):2177–81.

    Article  PubMed  Google Scholar 

  44. Margulis V, Youssef RF, Karakiewicz PI, Lotan Y, Wood CG, Zigeuner R, Kikuchi E, Weizer A, Raman JD, Remzi M, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Shariat SF, Upper Tract Urothelial Carcinoma Collaborative Group. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol. 2010;184(2):453–8.

    Article  PubMed  Google Scholar 

  45. Fernández MI, Shariat SF, Margulis V, Bolenz C, Montorsi F, Suardi N, Remzi M, Wood CG, Roscigno M, Kikuchi E, Oya M, Zigeuner R, Langner C, Weizer A, Lotan Y, Koppie TM, Raman JD, Karakiewicz P, Bensalah K, Schultz M, Bernier P. Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study. Urology. 2009;73(1): 142–6.

    Article  PubMed  Google Scholar 

  46. Lughezzani G, Sun M, Perrotte P, Shariat SF, Jeldres C, Budäus L, Latour M, Widmer H, Duclos A, Bénard F, McCormack M, Montorsi F, Karakiewicz PI. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Urology. 2010;75(2):321–7.

    Article  PubMed  Google Scholar 

  47. Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Tritschler S, Baba S, Matsushita K, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Otto W, Karakiewicz PI, Ficarra V, Novara G. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2011;29(4):481–6.

    Article  PubMed  Google Scholar 

  48. Shariat SF, Godoy G, Lotan Y, Droller M, Karakiewicz PI, Raman JD, Isbarn H, Weizer A, Remzi M, Roscigno M, Kikuchi E, Bolenz C, Bensalah K, Koppie TM, Kassouf W, Wheat JC, Zigeuner R, Langner C, Wood CG, Margulis V. Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int. 2010; 105(12):1672–7.

    Article  PubMed  Google Scholar 

  49. Ng CK, Shariat SF, Lucas SM, Bagrodia A, Lotan Y, Scherr DS, Raman JD. Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma? Urol Oncol. 2011;29(1):27–32.

    Article  PubMed  Google Scholar 

  50. Eltz S, Comperat E, Cussenot O, Rouprêt M. Molecular and histological markers in urothelial carcinomas of the upper urinary tract. BJU Int. 2008;102(5):532–5.

    Article  PubMed  CAS  Google Scholar 

  51. Holmäng S, Johansson SL. Bilateral metachronous ureteral and renal pelvic carcinomas: incidence, clinical presentation, histopathology, treatment and outcome. J Urol. 2006;175(1):69–72.

    Article  PubMed  Google Scholar 

  52. Huben RP, Mounzer AM, Murphy GP. Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer. 1988;62(9):2016–20.

    Article  PubMed  CAS  Google Scholar 

  53. Bariol SV, Stewart GD, McNeill SA, Tolley DA. Oncological control following laparoscopic nephroureterectomy: 7-year outcome. J Urol. 2004;172: 1805–8.

    Article  PubMed  Google Scholar 

  54. Jeldres C, Lughezzani G, Sun M, Isbarn H, Shariat SF, Budaus L, Lattouf JB, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI. Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter. J Urol. 2010;183(4):1324–9.

    Article  PubMed  Google Scholar 

  55. Thompson RH, Krambeck AE, Lohse CM, Elliott DS, Patterson DE, Blute ML. Elective endoscopic management of transitional cell carcinoma first ­diagnosed in the upper urinary tract. BJU Int. 2008;102(9): 1107–10.

    Article  PubMed  Google Scholar 

  56. Soderdahl DW, Fabrizio MD, Rahman NU, Jarrett TW, Bagley DH. Endoscopic treatment of upper tract transitional cell carcinoma. Urol Oncol. 2005;23: 114–22.

    Article  PubMed  Google Scholar 

  57. Palou J, Piovesan LF, Huguet J, Salvador J, Vicente J, Villavicencio H. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term follow-up. J Urol. 2004;172:66–9.

    Article  PubMed  Google Scholar 

  58. Grasso M, Bagley D. A 7.5/8.2F actively deflectable, flexible ureteroscope: a new device for both diagnostic and therapeutic upper urinary tract endoscopy. Urology. 1994;43:435–41.

    Article  PubMed  CAS  Google Scholar 

  59. Keeley FX, Bagley DH. Adjuvant mitomycin C following endoscopic treatment of upper tract transitional cell carcinoma. J Urol. 1997;158:2074–7.

    Article  PubMed  CAS  Google Scholar 

  60. Eastham JA, Huffman JL. Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors. J Urol. 1993;150(2):324–5.

    PubMed  CAS  Google Scholar 

  61. Elliott DS, Blute ML, Patterson DE, Bergstralh EJ, Segura JW. Long-term follow-up of endoscopically treated upper tract transitional cell carcinoma. Urology. 1996;47(6):819–25.

    Article  PubMed  CAS  Google Scholar 

  62. Martínez-Piñeiro JA, García Matres MJ, Martínez-Piñeiro L. Endourological treatment of upper tract urothelial carcinoma: analysis of a series of 59 tumors. J Urol. 1996;156(2):377–85.

    Article  PubMed  Google Scholar 

  63. Schnapp DS, Weiss GH, Smith AD. Fever following intracavitary bacillus Calmette-Guerin therapy for upper tract transitional cell carcinoma. J Urol. 1996;156(2):386–8.

    Article  PubMed  CAS  Google Scholar 

  64. Sharpe JR, Duffy G, Chin JL. Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ. J Urol. 1993;149:457–60.

    PubMed  CAS  Google Scholar 

  65. Schoenberg MP, Van Arsdalen KN, Wein AJ. The management of transitional cell carcinoma in solitary renal units. J Urol. 1991;146(3):700–2.

    PubMed  CAS  Google Scholar 

  66. Nonomura N, Ono Y, Nozawa M, Fukui T, Harada Y, Nishimura K, Takaha N, Takahara S, Okuyama A. Bacillus Calmette-Guerin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract. Eur Urol. 2000;38(6): 701–4.

    Article  PubMed  CAS  Google Scholar 

  67. Thalmann GN, Markwalder R, Walter B, Studer UE. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol. 2002;168(4):1381–5.

    Article  PubMed  Google Scholar 

  68. Rouprêt M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P, Bitker MO, Gattegno B, Richard F, Cussenot O. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology. 2006;67:1181–7.

    Article  PubMed  Google Scholar 

  69. Boorjian S, Ng C, Munver R, Palese MA, Vaughan Jr ED, Sosa RE, Del Pizzo JJ, Scherr DS. Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation in upper tract transitional cell carcinoma. Urology. 2005;66(2): 283–7.

    Article  PubMed  Google Scholar 

  70. Hendin BN, Streem SB, Levin HS, Klein EA, Novick AC. Impact of diagnostic ureteroscopy on long-term survival in patients with upper tract transitional cell carcinoma. J Urol. 1999;161(3):783–5.

    Article  PubMed  CAS  Google Scholar 

  71. Kulp DA, Bagley DH. Does flexible ureteropyeloscopy promote local recurrence of transitional cell carcinoma? J Endourol. 1994;8(2):111–3.

    Article  PubMed  CAS  Google Scholar 

  72. Fernández M, Bolenz C, Michel M-S, Alken P. Upper tract urothelial carcinoma: prognostic factors in 139 patients with a maximum follow-up of 16 years. Aktuelle Urol. 2006;37(S1):32.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bristol Urological Institute, Southmead Hospital, Bristol, UK

    Matthew H. C. Goh M.B.Ch.B., M.R.C.S. (Eng.), F.R.C.S. (Urol), Richard A. F. Pellatt M.B.Ch.B, B.A. (Hons) & Francis X. Keeley Jr. M.D., F.R.C.S. (Ed.), F.R.C.S. (Urol)

Authors
  1. Matthew H. C. Goh M.B.Ch.B., M.R.C.S. (Eng.), F.R.C.S. (Urol)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard A. F. Pellatt M.B.Ch.B, B.A. (Hons)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francis X. Keeley Jr. M.D., F.R.C.S. (Ed.), F.R.C.S. (Urol)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew H. C. Goh M.B.Ch.B., M.R.C.S. (Eng.), F.R.C.S. (Urol) .

Editor information

Editors and Affiliations

  1. Glickman Urological & Kidney Institute, Department of Urology, The Cleveland Clinic, 2842 Fontenay Road, Cleveland, 44120, Ohio, USA

    Manoj Monga

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Goh, M.H.C., Pellatt, R.A.F., Keeley, F.X. (2013). Transitional Cell Cancer. In: Monga, M. (eds) Ureteroscopy. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-206-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-206-3_6

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-205-6

  • Online ISBN: 978-1-62703-206-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation